Literature DB >> 26690023

Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria.

Peter Hillmen1, Petra Muus2, Jeffrey Szer3, Anita Hill4, Britta Höchsmann5, Austin Kulasekararaj6, Antonio M Risitano7, Eric Van Den Neste8, Maria Liljeholm9, Kurt S Ebrahim10, Camille L Bedrosian11, Xiang Gao11, Donna Ames11, Gérard Socié12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26690023     DOI： 10.1002/ajh.24280

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.

Authors:  Deniz Goren Sahin; Olga Meltem Akay; Muzaffer Keklik; Vahap Okan; Abdullah Karakus; Cengiz Demir; Mehmet Ali Erkurt; Kadir Ilkkilic; Rahsan Yildirim; Gulsum Akgun Cagliyan; Salih Aksu; Mehmet Hilmi Dogu; Mehmet Sinan Dal; Volkan Karakus; Ali Ihsan Gemici; Hatice Terzi; Engin Kelkitli; Serdar Sivgin; Ali Unal; Mehmet Yilmaz; Orhan Ayyildiz; Serdal Korkmaz; Bulent Eser; Fevzi Altuntas
Journal:  Ann Hematol       Date:  2021-05-14       Impact factor: 3.673

Review 2.  New milestones ahead in complement-targeted therapy.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Semin Immunol       Date:  2016-06-16       Impact factor: 11.130

Review 3.  Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab.

Authors:  Kioa Lente Wijnsma; Rob Ter Heine; Dirk Jan A R Moes; Saskia Langemeijer; Saskia E M Schols; Elena B Volokhina; Lambertus P van den Heuvel; Jack F M Wetzels; Nicole C A J van de Kar; Roger J Brüggemann
Journal:  Clin Pharmacokinet       Date:  2019-07       Impact factor: 6.447

Review 4.  The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies.

Authors:  Anna Vaisman-Mentesh; Matias Gutierrez-Gonzalez; Brandon J DeKosky; Yariv Wine
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.